Agree on all points. I just think as I mentioned earlier there are numerous degree of success and failure and market perception of such to be factored in
There is also the upcoming 'streamlining' of the FDA and the ability of our team to negotiate the best deal possible be it licensing or takeover.
There are easily conceived scenarios where 30c will barely present a speed bump (this is not me trying to ramp!) 2c is absolute worst case which makes the risk / reward so damn exciting...
The prospect of Accelerated Approval, page-18
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.56 |
Change
-0.400(2.67%) |
Mkt cap ! $1.860B | |||
| Open | High | Low | Value | Volume |
| $14.96 | $15.00 | $14.18 | $7.303M | 503.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 30783 | $14.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.60 | 1006 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |